The CONSORT statement: revised recommendations for improving the quality of reports of parallel-group randomised trials - PubMed (original) (raw)
. 2001 Apr 14;357(9263):1191-4.
Affiliations
- PMID: 11323066
The CONSORT statement: revised recommendations for improving the quality of reports of parallel-group randomised trials
D Moher et al. Lancet. 2001.
Abstract
To comprehend the results of a randomised controlled trial (RCT), readers must understand its design, conduct, analysis, and interpretation. That goal can be achieved only through total transparency from authors. Despite several decades of educational efforts, the reporting of RCTs needs improvement. Investigators and editors developed the original CONSORT (Consolidated Standards of Reporting Trials) statement to help authors improve reporting by use of a checklist and flow diagram. The revised CONSORT statement presented here incorporates new evidence and addresses some criticisms of the original statement. The checklist items pertain to the content of the Title, Abstract, Introduction, Methods, Results, and Discussion. The revised checklist includes 22 items selected because empirical evidence indicates that not reporting this information is associated with biased estimates of treatment effect, or because the information is essential to judge the reliability or relevance of the findings. We intended the flow diagram to depict the passage of participants through an RCT. The revised flow diagram depicts information from four stages of a trial (enrollment, intervention allocation, follow-up, and analysis). The diagram explicitly shows the number of participants, for each intervention group, included in the primary data analysis. Inclusion of these numbers allows the reader to judge whether the authors have done an intention-to-treat analysis. In sum, the CONSORT statement is intended to improve the reporting of an RCT, enabling readers to understand a trial's conduct and to assess the validity of its results.
Comment in
- Reporting of randomised controlled trials.
Counsell C. Counsell C. Lancet. 2001 Aug 18;358(9281):585. doi: 10.1016/S0140-6736(01)05727-0. Lancet. 2001. PMID: 11526927 No abstract available.
Similar articles
- The CONSORT statement: revised recommendations for improving the quality of reports of parallel-group randomized trials.
Moher D, Schulz KF, Altman DG; CONSORT Group (Consolidated Standards of Reporting Trials). Moher D, et al. J Am Podiatr Med Assoc. 2001 Sep;91(8):437-42. doi: 10.7547/87507315-91-8-437. J Am Podiatr Med Assoc. 2001. PMID: 11574648 - The CONSORT statement: revised recommendations for improving the quality of reports of parallel-group randomised trials.
Moher D, Schulz KF, Altman DG; CONSORT Group. Moher D, et al. Clin Oral Investig. 2003 Mar;7(1):2-7. doi: 10.1007/s00784-002-0188-x. Epub 2003 Jan 31. Clin Oral Investig. 2003. PMID: 12673431 - The CONSORT Statement: revised recommendations for improving the quality of reports of parallel-group randomized trials 2001.
Moher D, Schulz KF, Altman D; CONSORT Group. Moher D, et al. Explore (NY). 2005 Jan;1(1):40-5. doi: 10.1016/j.explore.2004.11.001. Explore (NY). 2005. PMID: 16791967 - The CONSORT statement: revised recommendations for improving the quality of reports of parallel-group randomized trials.
Moher D, Schulz KF, Altman DG; CONSORT GROUP (Consolidated Standards of Reporting Trials). Moher D, et al. Ann Intern Med. 2001 Apr 17;134(8):657-62. doi: 10.7326/0003-4819-134-8-200104170-00011. Ann Intern Med. 2001. PMID: 11304106 Review. - The CONSORT statement: revised recommendations for improving the quality of reports of parallel-group randomized trials.
Moher D, Schulz KF, Altman D; CONSORT Group (Consolidated Standards of Reporting Trials). Moher D, et al. JAMA. 2001 Apr 18;285(15):1987-91. doi: 10.1001/jama.285.15.1987. JAMA. 2001. PMID: 11308435 Review.
Cited by
- Effect of adjunctive photodynamic therapy on gingival crevicular fluid interleukin-1β in Stage III and IV periodontitis: A systematic review and meta-analysis.
Karrabi M, Baghani Z, Atarbashi-Moghadam F. Karrabi M, et al. J Indian Soc Periodontol. 2024 Mar-Apr;28(2):156-175. doi: 10.4103/jisp.jisp_494_23. Epub 2024 Aug 31. J Indian Soc Periodontol. 2024. PMID: 39411741 Free PMC article. Review. - Evaluating Compliance of Randomized Controlled Trial Abstracts in Plastic Surgery Journals with CONSORT Guidelines Using GPT-4 AI.
Al Qurashi AA, Hajja A, Alabdul Razzak GF, Alkuwaity DW, Chaudhri EN, Alharbi RI, Al Dwehji AMO, Almusa HA, Asaad AH, Alobaidi HA, Halawani IR, Gelidan AG. Al Qurashi AA, et al. Plast Reconstr Surg Glob Open. 2024 Oct 11;12(10):e6227. doi: 10.1097/GOX.0000000000006227. eCollection 2024 Oct. Plast Reconstr Surg Glob Open. 2024. PMID: 39399807 Free PMC article. - A Critical Appraisal of Reporting in Randomized Controlled Trials Investigating Osteopathic Manipulative Treatment: A Meta-Research Study.
Zambonin Mazzoleni G, Bergna A, Buffone F, Sacchi A, Misseroni S, Tramontano M, Dal Farra F. Zambonin Mazzoleni G, et al. J Clin Med. 2024 Aug 31;13(17):5181. doi: 10.3390/jcm13175181. J Clin Med. 2024. PMID: 39274394 Free PMC article. Review. - Effects of the teach-back method on the health status of patients with chronic obstructive pulmonary disease: a real-world community-based cluster-randomized controlled trial.
Zhang P, Zhu Y, Wang Y, Zhang W, Qiao C, Lou H, Liu Y, Dong D, Zhu X, Chen B. Zhang P, et al. J Thorac Dis. 2024 Aug 31;16(8):5209-5221. doi: 10.21037/jtd-23-1895. Epub 2024 Aug 26. J Thorac Dis. 2024. PMID: 39268140 Free PMC article. - Rotation or change of biotherapy after TNF blocker treatment failure for axial spondyloarthritis: the ROC-SpA study, a randomised controlled study protocol.
Dalix E, Marcelli C, Bejan-Angoulvant T, Finckh A, Rancon F, Akrour M, De Araujo L, Presles E, Marotte H; ROC-SpA study group. Dalix E, et al. BMJ Open. 2024 Sep 10;14(9):e087872. doi: 10.1136/bmjopen-2024-087872. BMJ Open. 2024. PMID: 39260856 Free PMC article.